Strata Develops Gene Validation Technology | GenomeWeb

ALAMEDA, Calif.--Strata Biosciences, a privately funded genomics company here, said it has developed proprietary tools with the capacity to knock out 100 genes per month using multiple vector systems, in an effort to attach functional relevance to gene sequences, discover disease-relevant genes, validate targets, and determine gene members of biological pathways.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.